| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6826340 | Schizophrenia Research | 2013 | 7 Pages |
Abstract
MK-0249 10Â mg once daily was not superior to placebo in the treatment of cognitive impairment in patients with schizophrenia after 4-weeks. (Clinicaltrials.gov: NCT00506077)
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Michael F. Egan, Xin Zhao, Regina Gottwald, Lyn Harper-Mozley, Ying Zhang, Duane Snavely, Christopher Lines, David Michelson,